Background Allergic contact dermatitis caused by biocides is common and causes significant patient morbidity.
Introduction
Preservatives are biocide chemicals added to cosmetics and household, pharmaceutical and industrial products to prevent the growth of microorganisms that may enter during manufacture or during usage, thereby prolonging the shelf life and the period of use of the products. 1, 2 Although preservatives can be regarded as indispensable agents, many of them have long been recognized as important skin sensitizers and constitute common causes of both occupational and non-occupational contact dermatitis. [1] [2] [3] [4] Some of the biocide allergens have been responsible for contact allergy outbreaks over the last century, such as the one caused by formaldehyde in the 1950s and 1960s as a result of cutaneous exposure to textile finishes and cosmetics. 5, 6 The introduction of methylchloroisothiazolinone (MCI)/ methylisothiazolinone (MI) resulted in another outbreak in the early 1980s, primarily attributed to cosmetic leave-on products, leading to strict regulations regarding its use. 7 Later, the use of methyldibromo glutaronitrile (MDBGN) in cosmetic products resulted in the third outbreak, which peaked in the late 1990s and early 2000s. The increasing rates of sensitization to MDBGN prompted the European Commission to restrict its use in leaveon and rinse-off cosmetics. 8, 9 More recently, MI as a single agent was introduced for use in industrial products around the year 2000 and in cosmetics in 2005. In the last years, many centres have reported an unprecedented increase in sensitization rates to both MI and MCI/MI. 10, 11 Therefore, the knowledge of the clinical and epidemiological features of contact allergy to biocide allergens, along with analyses of time trends, is of critical importance. On the basis of data collected over a 4-year period by the European Surveillance System on Contact Allergies (ESSCA) (www.essca-dc.org) network, this study describes the current frequency and pattern of patch test reactivity to preservatives, some included in the European baseline series (EBS) and some others previously recommended by the ESSCA to be patch tested routinely.
Materials and methods
Retrospective analysis based on data collected by the ESSCA network. 12 Clinical and demographic data along with patch test results of all patients tested are documented electronically using diverse data capture software and partly the multilingual software WinAlldat/ESSCA provided by the ESSCA. 13 with an additional set of allergens using investigator-loaded chambers and petrolatum-or water-based allergens to achieve a better coverage of the desired range of allergens and concordance with the EBS, i.e. fragrance mix II, hydroxisohexyl 3-cyclohexene carboxaldehyde (HICC), MDBGN, sesquiterpene lactone mix, primin and, more recently, MI. 20 The biocides contained in the EBS and further allergens listed in Table 1 were tested in consecutive patients. Please note that in case of biocides there are partly different test concentrations used because of lack of ESCD recommendations at that time. The corresponding results have been analysed separately.
Results

Prevalence of preservative contact allergy
The overall results with the petrolatum-and water-based allergens, all tested in consecutive patients, be it only in certain periods or by a subset of departments only, are presented in Table 1 . Overall results include stratification by sex and age (dichotomized). Methylisothiazolinone registered the highest prevalence of sensitization, with 4.9% positive reactions (agestandardized and sex-standardized) of 4755 tested patients at 0.05% aq., and 4.5% positive reactions of 3382 tested patients at 0.2% aq. (MI at 0.1% aq. was patch tested in only 141 patients). The combination MCI/MI, tested at concentration of 0.02% aq., followed closely, with 4.1% of positive reactions. Other preservatives with lower prevalences, but still over 1%, include MDBGN, the mixture methyldibromo glutaronitrile+ 2-phenoxyethanol, iodopropynyl butylcarbamate (IPBC) and formaldehyde 1%. Other biocides, such as formaldehyde 2% (albeit tested in a still limited number of patients), formaldehyde releasers and parabens, yielded less than 1% of positive reactions during the study period.
The results obtained with the biocide allergens available in the TRUE-test â , including stratification by sex and age, are shown in Table 2 . A wide range of frequencies of positive patch test reactions was found, with the highest prevalence for MCI/MI with 7.5% of positive reactions. At the other end, the paraben mix yielded only 0.4% positive reactions. The distribution of reaction grades as compared with investigator-loaded and petrolatumbased allergens varied slightly with a lower proportion of irritant/ doubtful reactions (with the exception of formaldehyde and imidazolidinyl urea) and a higher share of weak (+) reactions (except for paraben mix) for the TRUE-Test â allergen preparations.
Prevalence by country
A breakdown of test results by country is shown in ' Table S1 0 .
Some allergens showed marked differences in the frequency of sensitization between European countries, with the highest values seen for MCI/MI tested at 0.02% aq. in Finland and Spain (8.9% and 6.9%, respectively) compared with the United Kingdom (4.2%). The variability of sensitization to other biocide allergens was on a lower level, e.g. quaternium-15, which showed a prevalence of sensitization ranging from 0.3% to 1.9% in the 10 countries analysed, and the paraben mix, which ranged from 0.2% to 1.9% in the 11 countries analysed.
Formaldehyde and formaldehyde releasers
The characteristics of patients positive to a set of four formaldehyde releasers and of patients with positive reactions to either 1% or 2% formaldehyde are shown in Table 3 . The formaldehyde releasers with higher co-reactions to formaldehyde were quaternium-15 (39.5%) and diazolidinyl urea (26.4%). On the other hand, just 7.4% of the 2-bromo-2-nitropropane-1,3-diol (Bronopol â ) sensitive patients also reacted to formaldehyde.
Methyldibromo glutaronitrile
The MOAHLFA index in patients patch tested and in patients positive to MDBGN, as well as the proportion of patients tested with the three different concentrations, stratified for three age groups are presented in Table 4 . Note that the prevalence of positive reactions to MDBGN was higher in the 'old' and 'middle' age groups than in the youngest age group at the three different concentrations tested. The time trend regarding MDBGN is shown in Fig. 1 . It should be noted that three different patch test concentrations have been used in the study period, namely, 0.2%, 0.3% and 0.5% pet. The usage across the different departments differed significantly between the years (P < 0.001, v Fig. 1 , stratified for age group, with pooled results from all three concentrations, should be interpreted with some caution, as they are confounded, to some extent, by the above factor. Statistical analysis, however, does confirm the notion of an upward trend for the two older groups, and a largely stable prevalence for the youngest age group both in a bivariate and an adjusted analysis considering potential confounding by test concentration, sex and country (P < 0.001).
Methylchloroisothiazolinone/methylisothiazolinone (3 : 1) and methylisothiazolinone
The time trend regarding MCI/MI, stratified for sex and age group, is presented in Fig. 2 . MCI/MI had been tested in the baseline series throughout the study period; however, its test concentrations had been increased in some departments, respectively, pre-empting the ESCD recommendation in the course of the study period. 20 In this case, also taking into account the possibility of detecting a large proportion of MI contact allergy with MCI/MI tested at 200 ppm, both test concentrations were Table 3 MOAHLFA index (male, occupational, atopic dermatitis, hand eczema, leg dermatitis, facial dermatitis and age ≥40 years) in all patients patch tested (first row) and in patients positive to formaldehyde and formaldehyde releasers, respectively. For this analysis, different concentrations of an allergen (see Table 1 ) and TRUE-test â allergens were regarded equivalent and pooled. 'pos.(F'ald.)'; proportion of patients positive to the allergen in the row, who also had positive reactions to formaldehyde. '% of F'ald. pos'; proportion of patients positive to formaldehyde (tested with the allergen in the row) who are also positive to the allergen in the row 
Discussion
The overall results show that the most important preservatives, in terms of frequency of contact sensitization, are currently the isothiazolinones (MI and MCI/MI) and MDBGN. Sensitization frequencies for these biocides were greater than 1% during this period, justifying their inclusion in the baseline series. Although formaldehyde 2.0% aq. is the currently recommended patch test concentration, [21] [22] [23] [24] the frequency of sensitization registered was less than 1%. However, this result should not be over-interpreted, as different patients had been tested with the two concentrations, a comparison of the 'diagnostic yield' of (relevant) test reactions cannot be made. The paraben mix and formaldehyde releasers, such as Bronopol â , imidazolidinyl urea, diazolidinyl urea and quaternium-15, did not reach the 1% threshold of positive reactions in consecutive patients; therefore, their inclusion in the EBS should be discussed. As with previous ESSCA studies, 12, 25 regional variation in the prevalence of sensitization was observed. Differences were particularly noted for formaldehyde, MI/MCI and MDBGN. For example, The Netherlands shows a particular high prevalence of the following biocides: 2.5% and 3.4% reacted to formaldehyde 1% and 2% aq., respectively; 8.6% reacted to MCI/MI 0.01% aq.; and 6.9% reacted to MDBGN 0.3% pet. In the other extreme, United Kingdom reported the lowest prevalence of sensitization to formaldehyde 1% and 2% aq. (1.2% and 1.0% contact allergy prevalence, respectively), MCI/MI 0.02% aq. (4.2%) and MDBGN 0.3% pet. (0.6%). In spite of a common EU regulation -at least concerning exposure via cosmetics -such national or regional differences in the prevalence of sensitivity among European countries are observed. 26 These differences could be attributable to differences in exposure or characteristics of the population tested. Cosmetic-related contact allergy has been considered to be related to facial dermatitis; indeed, facial dermatitis is about twice as common in patients allergic to formaldehyde releasers, which are typically cosmetic preservatives, than in the general patch test patients (Table 3) . 27 Furthermore, despite all efforts for standardization, this regional variation may partly be explained by residual methodological variation in a network of such a scope. MDBGN was launched in the 1980s for use in industrial and cosmetic products. Due to an increase in the prevalence of contact allergy to MDBGN registered in the 2000s, 3 (MCI/MI) was responsible of an increasing number of allergic patients in the 1980s. Nowadays, MCI/MI is completely banned from use in leave-on products in Europe. 32 However, several years ago, MI was introduced as a stand-alone preservative in skin care products and cosmetics (at a maximum use concentration of 100 ppm). 33 Since then, an alarming and unprecedented increase in the prevalence of sensitization to both MCI/MI and MI has been reported. 11, 34 Our analysis shows similar results, and a prevalence of contact allergy to MCI/MI of 3.3-4.1% and to MI of 4.5-4.9% was found during the study period. The presented ESSCA data on MI alone are somewhat limited in terms of geographical coverage and only show the very beginning of the increased frequency of contact allergy due to MI reported elsewhere. Following regulatory action for these two preservatives, the impact on sensitization frequencies in the future should be monitored.
Formaldehyde is a difficult allergen to test, as most of the allergic reactions are only weakly positive, although they often have a clinical relevance. 35 When patients are tested with formaldehyde and one or more formaldehyde releasers, concomitant positive reactions may be observed. 3, [36] [37] [38] However, there is currently insufficient evidence regarding whether formaldehyde releasers present a risk for patients who are allergic to formaldehyde. One reason is that it is impossible to determine the levels of free formaldehyde in products containing formaldehyde releasers, as a wide range of factors can influence the amount of free formaldehyde released. 38 Previous studies
showed that just 15% of the Bronopol â -positive patients also reacted to formaldehyde, while a higher percentage (40-60%) of the patients reacting to the other releasers also reacted to formaldehyde. 38 In our study, these rates of cross-reactivity between formaldehyde and formaldehyde releasers were considerably lower: only 7% of all reactions to Bronopol â and 21-40%
of the reactions to the other releasers are associated with a positive patch test reaction to formaldehyde. Similar results were found in a recent study from the IVDK, 3 with 5% of cross-reactivity for Bronopol â and 16-47% for the other releasers.
Notwithstanding, the recommendation of advising patients who are allergic to formaldehyde to avoid leave-on cosmetics preserved with formaldehyde releasers, especially when are used regularly and/or on 'sensitive' or damaged skin, seems very reasonable. 38 If there would be no alternative, Bronopol â -containing products would probably be the safest option, as most patch test reactions to Bronopol â are caused by a sensitivity to this preservative per se and are not related to formaldehyde allergy. 39 Other biocide allergens include parabens and IPBC. Since the 1990s, the prevalence of sensitization to parabens has been relatively stable in Europe around 0.5%-1%. 4, 12, 28 Although the IVDK found a sensitization rate of 1.3% between the years 1996 and 2009, a decreasing trend was noted. 3 In the current analysis, the prevalence of contact allergy to parabens has apparently remained stable in the last few years, with an overall sensitization frequency of 0.7% between 2009 and 2012. Conversely, IPBC, a small lipophilic molecule that may readily penetrate the skin, is an emerging allergen with an increasing prevalence over the last few years. This preservative is now being used with increasing frequency, especially in cosmetic products. 40 The sensitization frequency to IPBC in Europe varied from 0.2% to 0.3% in the late 1990s to 0.6% from 2000 to 2011. [41] [42] [43] The IVDK showed a prevalence of contact allergy of 0.9% between 1996 and 2009, with an increase in the last years. In conclusion, preservatives are nowadays one of the major causes of contact allergy. MI, with an overall prevalence of sensitization during 2009-2012 of 4.5%, is a current problem across Europe. Although MDBGN is banned from leave-on and rinse-off products since 2005, sensitized patients are still diagnosed, suggesting other non-regulated sources of exposure. Prevalence of contact allergy to parabens has remained stable in the last years, whereas IPBC is an emerging allergen with an increasing prevalence. Regional differences in the prevalence of sensitivity among European countries could be explained by differences in exposure and test populations. Continued surveillance is needed to monitor the impact of biocides allergens across Europe. 
